Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;11(3):425-429.
doi: 10.21037/hbsn-22-9.

Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival

Seren M Gedallovich  1 , Daniela P Ladner  2 , Lisa B VanWagner  3   4
Affiliations
Editorial

Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival

Seren M Gedallovich et al. Hepatobiliary Surg Nutr. 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-22-9/coif). LBV receives grant support from W.L. Gore & Associates, Intercept Pharmaceuticals and AMRA Medical outside the current work; consults for Gerson Lehrman group and serves as an expert witness. The other authors have no conflicts of interest to declare.

References

    1. Croome KP, Lee DD, Taner CB. The "Skinny" on assessment and utilization of steatotic liver grafts: a systematic review. Liver Transpl 2019;25:488-99. 10.1002/lt.25408 - DOI - PubMed
    1. Eslam M, Sanyal AJ, George J, et al. MAFLD: A Consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158:1999-2014.e1. 10.1053/j.gastro.2019.11.312 - DOI - PubMed
    1. Cleveland E, Bandy A, VanWagner LB. Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Clin Liver Dis (Hoboken) 2018;11:98-104. 10.1002/cld.716 - DOI - PMC - PubMed
    1. Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018;67:123-33. 10.1002/hep.29466 - DOI - PMC - PubMed
    1. Imber CJ, St Peter SD, Lopez I, et al. Current practice regarding the use of fatty livers: a trans-Atlantic survey. Liver Transpl 2002;8:545-9. 10.1053/jlts.2002.31747 - DOI - PubMed

Publication types